Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more than 20…
BRISBANE, Australia, Sept. 14, 2021 /PRNewswire/ — Symplicity Corporation is happy to announce its latest strategic global partnership with De La Salle University, the…
Acquisition Establishes Company’s Footprint in Australia and New Zealand ST. LOUIS, Sept. 14, 2021 /PRNewswire/ – Global packaging leader TricorBraun announced…
Both business and STEM talent in Australia see Google as the most ideal choice SYDNEY, Sept. 14, 2021 /PRNewswire/ —…
MELBOURNE, Australia, Sept. 14, 2021 /PRNewswire/ – Fundsquire, a source of capital for startup and scale-ups globally, today announced they have…
PowerScribe One enhances reporting quality and efficiency and reduces radiologist fatigue while mPower uses data-driven insights to decrease failed follow-ups…
AVAILABLE EXCLUSIVELY AT PLATYPUS AND CROCS AUSTRALIA SYDNEY, Sept. 13, 2021 /PRNewswire/ — Crocs, INC. (NADSAQ: CROX), a global leader…
SYDNEY, Sept. 13, 2021 /PRNewswire/ – MRI Software, a global leader in real estate software, today announces its acquisition of industry-leading customer…
MELBOURNE, Australia, Sept. 13, 2021 /PRNewswire/ – Do you have dynamite skills but aren’t sure how to make the most of…
SYDNEY, Sept. 11, 2021 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased…
